NYSE:MED - Medifast Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$140.58 -0.35 (-0.25 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$140.58
Today's Range$139.05 - $141.3404
52-Week Range$40.00 - $141.34
Volume151,903 shs
Average Volume200,967 shs
Market Capitalization$1.70 billion
P/E Ratio61.39
Dividend Yield1.36%
Beta0.25

About Medifast (NYSE:MED)

Medifast logoMedifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:MED
CUSIP58470H10
Phone410-581-8042

Debt

Debt-to-Equity RatioN/A
Current Ratio3.43
Quick Ratio2.98

Price-To-Earnings

Trailing P/E Ratio61.39
Forward P/E Ratio38.52
P/E Growth2.57

Sales & Book Value

Annual Sales$301.56 million
Price / Sales5.62
Cash Flow$2.7276 per share
Price / Cash51.54
Book Value$9.42 per share
Price / Book14.92

Profitability

EPS (Most Recent Fiscal Year)$2.29
Net Income$27.72 million
Net Margins10.26%
Return on Equity31.11%
Return on Assets24.07%

Miscellaneous

Employees399
Outstanding Shares12,060,000

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Friday, March 16th. Investors of record on Friday, March 30th will be paid a dividend of $0.48 per share on Tuesday, May 8th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Wednesday, March 28th. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) posted its quarterly earnings results on Thursday, May, 3rd. The specialty retailer reported $1.01 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.86 by $0.15. The specialty retailer earned $98.60 million during the quarter, compared to analysts' expectations of $89.23 million. Medifast had a net margin of 10.26% and a return on equity of 31.11%. Medifast's revenue for the quarter was up 39.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.36 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus estimate of $3.24. The company issued revenue guidance of $385-395 million, compared to the consensus revenue estimate of $354.90 million.Medifast also updated its Q2 guidance to $0.94-0.97 EPS.

What price target have analysts set for MED?

2 brokerages have issued 12-month target prices for Medifast's shares. Their forecasts range from $55.00 to $161.00. On average, they anticipate Medifast's share price to reach $108.00 in the next year. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 53)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)
  • Mr. Bill Baker, Exec. VP of Information Technology (Age 46)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63)

Has Medifast been receiving favorable news coverage?

Media coverage about MED stock has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Medifast earned a daily sentiment score of 0.11 on Accern's scale. They also assigned press coverage about the specialty retailer an impact score of 47.50 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.40%), Millennium Management LLC (2.40%), American Century Companies Inc. (1.82%), Summit Trail Advisors LLC (1.45%), Northern Trust Corp (1.12%) and Old Mutual Global Investors UK Ltd. (1.09%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Which institutional investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., HL Financial Services LLC, BNP Paribas Arbitrage SA, Seizert Capital Partners LLC, JPMorgan Chase & Co., Wells Fargo & Company MN and GSA Capital Partners LLP. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.

Which institutional investors are buying Medifast stock?

MED stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Millennium Management LLC, Prudential Financial Inc., Great Lakes Advisors LLC, Allianz Asset Management GmbH, Allianz Asset Management GmbH, Landscape Capital Management L.L.C. and Old Mutual Global Investors UK Ltd.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $140.58.

How big of a company is Medifast?

Medifast has a market capitalization of $1.70 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


MarketBeat Community Rating for Medifast (MED)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  200 (Vote Underperform)
Total Votes:  378
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medifast (NYSE:MED) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Medifast in the last 12 months. Their average twelve-month price target is $108.00, suggesting that the stock has a possible downside of 23.18%. The high price target for MED is $161.00 and the low price target for MED is $55.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $108.00$81.50$72.00$64.50
Price Target Upside: 23.18% downside15.87% downside0.84% upside12.13% upside

Medifast (NYSE:MED) Consensus Price Target History

Price Target History for Medifast (NYSE:MED)

Medifast (NYSE:MED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2018DA DavidsonBoost Price TargetBuy ➝ Buy$135.00 ➝ $161.00HighView Rating Details
4/19/2018SidotiReiterated RatingBuy ➝ NeutralMediumView Rating Details
8/4/2016WunderlichBoost Price TargetHold$32.00 ➝ $36.00N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Medifast (NYSE:MED) Earnings History and Estimates Chart

Earnings by Quarter for Medifast (NYSE:MED)

Medifast (NYSE:MED) Earnings Estimates

2018 EPS Consensus Estimate: $3.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.86$0.86$0.86
Q2 20181$1.00$1.00$1.00
Q3 20181$0.94$0.94$0.94
Q4 20181$0.70$0.70$0.70

Medifast (NYSE MED) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2018        
5/3/2018Q1 2018$0.86$1.01$89.23 million$98.60 millionViewN/AView Earnings Details
3/6/2018Q4 2017$0.48$0.60$73.48 million$78.01 millionViewListenView Earnings Details
11/7/2017Q3 2017$0.51$0.55$74.94 million$77.20 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.63$71.96 million$75.70 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.49$0.51$72.36 million$70.62 millionViewListenView Earnings Details
3/9/2017Q4 2016$0.33$0.34$65.01 million$62.50 millionViewListenView Earnings Details
11/3/2016Q316$0.45$0.51$66.79 million$68.57 millionViewN/AView Earnings Details
8/3/2016Q216$0.51$0.63$72.01 million$71.14 millionViewN/AView Earnings Details
5/4/2016Q116$0.33$0.42$69.31 million$72.30 millionViewN/AView Earnings Details
3/10/2016Q415$0.35$0.33$62.98 million$61.30 millionViewListenView Earnings Details
11/5/2015Q315$0.42$0.45$67.00 million$65.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.48$0.48$72.79 million$72.20 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.46$71.80 million$73.30 millionViewN/AView Earnings Details
3/12/2015Q414$0.46$0.38$69.40 million$62.30 millionViewN/AView Earnings Details
11/5/2014Q314$0.36$0.47$76.10 million$74.00 millionViewN/AView Earnings Details
8/7/2014Q114$0.40$0.44$87.30 million$80.88 millionViewN/AView Earnings Details
5/5/2014Q1$0.37$0.45$87.60 million$86.50 millionViewN/AView Earnings Details
3/10/2014Q413$0.36$0.39$80.83 million$77.30 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.41$95.07 million$86.48 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.51$0.51$101.30 million$97.10 millionViewN/AView Earnings Details
5/8/2013Q1 2013$0.34$0.43$93.77 million$96.00 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.25$0.28$82.90 million$83.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.40$0.42$89.73 million$91.00 millionViewN/AView Earnings Details
7/26/2012$0.38$0.47ViewN/AView Earnings Details
5/8/2012$0.38$0.29ViewN/AView Earnings Details
3/13/2012$0.21$0.08ViewN/AView Earnings Details
11/3/2011$0.38$0.36ViewN/AView Earnings Details
8/4/2011$0.47$0.41ViewN/AView Earnings Details
5/9/2011$0.41$0.44ViewN/AView Earnings Details
3/31/2011$0.32$0.23ViewN/AView Earnings Details
11/4/2010Q3 2010$0.39$0.39ViewN/AView Earnings Details
8/5/2010Q2 2010$0.34$0.38ViewN/AView Earnings Details
5/5/2010Q1 2010$0.27$0.33ViewN/AView Earnings Details
3/4/2010Q4 2009$0.19$0.21ViewN/AView Earnings Details
10/29/2009Q3 2009$0.19$0.23ViewN/AView Earnings Details
7/30/2009Q2 2009$0.18$0.20ViewN/AView Earnings Details
4/29/2009Q1 2009$0.12$0.17ViewN/AView Earnings Details
3/12/2009Q4 2008$0.07ViewN/AView Earnings Details
11/6/2008Q3 2008$0.11$0.11ViewN/AView Earnings Details
8/7/2008Q2 2008$0.09$0.11ViewN/AView Earnings Details
5/12/2008Q1 2008$0.11$0.10ViewN/AView Earnings Details
3/12/2008Q4 2007$0.06$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Medifast (NYSE:MED) Dividend Information

Medifast pays an annual dividend of $1.92 per share, with a dividend yield of 1.37%. MED's most recent quarterly dividend payment was Tuesday, May 8. Medifast pays out 83.84% of its earnings out as a dividend.
Most Recent Dividend:5/8/2018
Annual Dividend:$1.92
Dividend Yield:1.37%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio(s):83.84% (Trailing 12 Months of Earnings)
52.60% (Based on This Year's Estimates)
42.67% (Based on Next Year's Estimates)
70.39% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medifast (NYSE:MED)

Medifast (NYSE:MED) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/16/2018quarterly$0.482.14%3/28/20183/30/20185/8/2018
12/7/2017quarterly$0.482.69%12/21/201712/22/20172/8/2018
9/7/2017quarterly$0.322.31%9/21/20179/22/201711/9/2017
6/7/2017Quarterly$0.323.1%6/21/20176/23/20178/9/2017
3/8/2017quarterly$0.322.92%3/21/20173/23/20175/9/2017
12/9/2016quarterly$0.323.13%12/21/201612/23/20162/9/2017
9/9/2016quarterly$0.252.75%9/21/20169/23/201611/10/2016
6/16/2016quarterly$0.253.04%6/23/20166/27/20168/10/2016
3/10/2016quarterly$0.253.25%3/17/20163/21/20165/10/2016
12/16/2015special$0.2512/23/201512/28/20152/10/2016
(Data available from 1/1/2013 forward)

Insider Trades

Medifast (NYSE MED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.47%
Institutional Ownership Percentage: 88.28%
Insider Trading History for Medifast (NYSE:MED)
Institutional Ownership by Quarter for Medifast (NYSE:MED)

Medifast (NYSE MED) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2018Charles P ConnollyDirectorSell8,000$90.95$727,600.0045,342View SEC Filing  
3/15/2018Charles P ConnollyDirectorSell7,500$89.31$669,825.0040,342View SEC Filing  
3/8/2018Michael C MacdonaldDirectorSell20,000$84.45$1,689,000.00334,188View SEC Filing  
12/1/2017Glenn W WellingDirectorSell275,000$64.60$17,765,000.00View SEC Filing  
11/13/2017Glenn W WellingDirectorSell250,000$65.00$16,250,000.00View SEC Filing  
9/21/2017Ralph RushtonDirectorSell25,000$0.18$4,500.00
9/6/2017Jeremy John MartinDirectorSell131,500$0.18$23,670.00
7/7/2017Simon T.P. RidgwayInsiderBuy1,500$0.15$225.00
7/5/2017Simon T.P. RidgwayInsiderBuy29,000$0.15$4,350.00
3/14/2017Glenn W WellingDirectorBuy17,084$41.33$706,081.725,309View SEC Filing  
11/15/2016Glenn W WellingDirectorBuy35,000$39.02$1,365,700.002,670View SEC Filing  
11/9/2016Jeffrey J BrownDirectorBuy10,000$38.71$387,100.0013,254View SEC Filing  
5/31/2016Balanced Master Fund L VisiumMajor ShareholderSell1,350,000$30.25$40,837,500.001,247,882View SEC Filing  
4/1/2016Margaret SheetzCOOSell8,333$30.02$250,156.66327,346View SEC Filing  
2/1/2016Margaret SheetzCOOSell8,333$28.62$238,490.46336,762View SEC Filing  
12/1/2015Margaret SheetzCOOSell8,333$29.92$249,323.36353,428View SEC Filing  
11/2/2015Margaret SheetzCOOSell8,333$28.72$239,323.76361,761View SEC Filing  
10/5/2015Margaret SheetzCOOSell8,333$28.88$240,657.04370,094View SEC Filing  
9/4/2015Simon T.P. RidgwayDirectorBuy4,000$0.08$320.00
9/3/2015Margaret SheetzCOOSell6,864$28.00$192,192.00378,427View SEC Filing  
9/2/2015Margaret SheetzCOOSell1,469$28.00$41,132.00385,291View SEC Filing  
9/1/2015Simon T.P. RidgwayDirectorBuy16,000$0.08$1,280.00
8/25/2015Simon T.P. RidgwayDirectorBuy1,000$0.0850$85.00
8/24/2015Simon T.P. RidgwayDirectorBuy2,000$0.09$180.00
8/19/2015Simon T.P. RidgwayDirectorBuy15,000$0.0950$1,425.00
8/18/2015Simon T.P. RidgwayDirectorBuy35,000$0.0950$3,325.00
8/17/2015Radius Gold Inc.InsiderBuy5,000$0.09$450.00
8/14/2015Radius Gold Inc.InsiderBuy35,000$0.10$3,500.00
8/14/2015Simon T.P. RidgwayDirectorBuy10,000$0.0950$950.00
6/25/2015Moduslink Global Solutions IncMajor ShareholderSell29,654$33.03$979,471.62View SEC Filing  
6/23/2015Moduslink Global Solutions IncMajor ShareholderSell27,443$33.01$905,893.43View SEC Filing  
6/22/2015Moduslink Global Solutions IncMajor ShareholderSell9,494$33.01$313,396.94View SEC Filing  
6/11/2015Barry B BondroffDirectorSell1,666$31.88$53,112.08View SEC Filing  
6/10/2015Margaret SheetzCOOSell8,337$32.00$266,784.00View SEC Filing  
6/4/2015John P McdanielDirectorSell3,000$32.14$96,420.00View SEC Filing  
8/18/2014Jeannette M MillsEVPSell3,000$28.03$84,090.00View SEC Filing  
6/10/2014Jason L GrovesEVPSell3,250$31.75$103,187.50View SEC Filing  
6/10/2014John P McdanielDirectorSell3,500$31.74$111,090.00View SEC Filing  
6/9/2014Jeannette M MillsEVPSell2,784$32.09$89,338.56View SEC Filing  
6/5/2014Charles P ConnollyDirectorSell7,500$30.91$231,825.00View SEC Filing  
12/2/2013Margaret Macdonald SheetzCOOSell18,000$25.63$461,340.00351,292View SEC Filing  
11/22/2013Margaret Macdonald SheetzCOOSell35,000$24.33$851,550.00369,292View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medifast (NYSE MED) News Headlines

Source:
DateHeadline
8 Biggest Price Target Changes For Thursday8 Biggest Price Target Changes For Thursday
www.benzinga.com - May 24 at 4:26 PM
DA Davidson Increases Medifast (MED) Price Target to $161.00DA Davidson Increases Medifast (MED) Price Target to $161.00
www.americanbankingnews.com - May 24 at 11:31 AM
Medifast (MED) PT Raised to $161 at DA Davidson; Asia alone could drive 25% sales growthMedifast (MED) PT Raised to $161 at DA Davidson; 'Asia alone could drive 25% sales growth'
www.streetinsider.com - May 24 at 9:38 AM
B&G Foods (BGS) Cheers Investors With 2.2% Dividend HikeB&G Foods (BGS) Cheers Investors With 2.2% Dividend Hike
finance.yahoo.com - May 23 at 4:30 PM
Zacks.com highlights: Medifast, Myriad Genetics, ICU Medical, Ellie Mae and UGIZacks.com highlights: Medifast, Myriad Genetics, ICU Medical, Ellie Mae and UGI
finance.yahoo.com - May 16 at 4:25 PM
DA Davidson Weighs in on Medifasts Q2 2018 Earnings (MED)DA Davidson Weighs in on Medifast's Q2 2018 Earnings (MED)
www.americanbankingnews.com - May 7 at 1:56 AM
Medifast (MED) Announces Quarterly  Earnings Results, Beats Estimates By $0.15 EPSMedifast (MED) Announces Quarterly Earnings Results, Beats Estimates By $0.15 EPS
www.americanbankingnews.com - May 5 at 3:07 PM
DA Davidson Increases Medifast (MED) Price Target to $135.00DA Davidson Increases Medifast (MED) Price Target to $135.00
www.americanbankingnews.com - May 4 at 11:27 PM
Medifast Q1 top line up 39%; earnings up 100%; revenue guidance raised; shares up 25%Medifast Q1 top line up 39%; earnings up 100%; revenue guidance raised; shares up 25%
seekingalpha.com - May 4 at 4:22 PM
Medifast Inc. (MED) Has Jumped To A New High On Q1 ResultsMedifast Inc. (MED) Has Jumped To A New High On Q1 Results
www.nasdaq.com - May 4 at 4:22 PM
Medifasts (MED) CEO Dan Chard on Q1 2018 Results - Earnings Call TranscriptMedifast's (MED) CEO Dan Chard on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:27 AM
Medifast (MED) Tops Q1 EPS by 15c; Offers FY18 OutlookMedifast (MED) Tops Q1 EPS by 15c; Offers FY18 Outlook
www.streetinsider.com - May 4 at 9:27 AM
Medifast shares surge after reporting profits doubled in 1QMedifast shares surge after reporting profits doubled in 1Q
finance.yahoo.com - May 4 at 9:27 AM
Cash in On DuPont Analysis, Buy 5 Top-Ranked StocksCash in On DuPont Analysis, Buy 5 Top-Ranked Stocks
finance.yahoo.com - May 4 at 9:27 AM
Edited Transcript of MED earnings conference call or presentation 3-May-18 8:30pm GMTEdited Transcript of MED earnings conference call or presentation 3-May-18 8:30pm GMT
finance.yahoo.com - May 4 at 9:27 AM
Medifast: 1Q Earnings SnapshotMedifast: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 9:27 AM
Medifast (MED) Releases FY18 Earnings GuidanceMedifast (MED) Releases FY18 Earnings Guidance
www.americanbankingnews.com - May 3 at 6:32 PM
Medifast (MED) Updates Q2 Earnings GuidanceMedifast (MED) Updates Q2 Earnings Guidance
www.americanbankingnews.com - May 3 at 6:32 PM
Medifast, Inc. Announces First Quarter 2018 Financial ResultsMedifast, Inc. Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 4:21 PM
Medifast CEO Daniel Chard gets a big bonus for boosting salesMedifast CEO Daniel Chard gets a big bonus for boosting sales
finance.yahoo.com - May 2 at 4:27 PM
Comparing Farmer Brothers (FARM) & Medifast (MED)Comparing Farmer Brothers (FARM) & Medifast (MED)
www.americanbankingnews.com - April 29 at 1:38 AM
Medifast (MED) Scheduled to Post Earnings on ThursdayMedifast (MED) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 26 at 4:08 AM
Head to Head Comparison: McCormick & Company, Incorporated (MKC) and Medifast (MED)Head to Head Comparison: McCormick & Company, Incorporated (MKC) and Medifast (MED)
www.americanbankingnews.com - April 25 at 7:30 PM
Gatheredtable software licensed by MedifastGatheredtable software licensed by Medifast
finance.yahoo.com - April 23 at 4:22 PM
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2018Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2018
finance.yahoo.com - April 20 at 9:45 AM
Sidoti Reaffirms "Neutral" Rating for Medifast (MED)Sidoti Reaffirms "Neutral" Rating for Medifast (MED)
www.americanbankingnews.com - April 19 at 2:24 PM
How Does Medifast Inc’s (NYSE:MED) Earnings Growth Stack Up Against Industry Performance?How Does Medifast Inc’s (NYSE:MED) Earnings Growth Stack Up Against Industry Performance?
finance.yahoo.com - April 18 at 9:34 AM
Market Volatility is Not a Worry With These 5 Low-Beta StocksMarket Volatility is Not a Worry With These 5 Low-Beta Stocks
finance.yahoo.com - April 13 at 9:59 AM
Analyzing Greencore Group (GNCGY) and Medifast (MED)Analyzing Greencore Group (GNCGY) and Medifast (MED)
www.americanbankingnews.com - April 7 at 10:10 AM
Financial Review: McCormick & Company, Incorporated (MKC) & Medifast (MED)Financial Review: McCormick & Company, Incorporated (MKC) & Medifast (MED)
www.americanbankingnews.com - April 4 at 9:34 PM
Bull of the Day: Medifast Inc. (MED)Bull of the Day: Medifast Inc. (MED)
finance.yahoo.com - April 4 at 5:08 PM
Medifast, Signet Jewelers and NVIDIA highlighted as Zacks Bull and Bear of the DayMedifast, Signet Jewelers and NVIDIA highlighted as Zacks Bull and Bear of the Day
finance.yahoo.com - April 4 at 5:08 PM
Earnings Estimates Moving Higher for Medifast (MED): Time to Buy?Earnings Estimates Moving Higher for Medifast (MED): Time to Buy?
finance.yahoo.com - April 4 at 5:08 PM
Medifast (MED) Lifted to Strong-Buy at ValuEngineMedifast (MED) Lifted to Strong-Buy at ValuEngine
www.americanbankingnews.com - April 3 at 12:10 PM
Critical Analysis: Medifast (MED) & Greencore Group (GNCGY)Critical Analysis: Medifast (MED) & Greencore Group (GNCGY)
www.americanbankingnews.com - April 2 at 7:16 PM
Zacks Investment Research Upgrades Medifast (MED) to "Buy"Zacks Investment Research Upgrades Medifast (MED) to "Buy"
www.americanbankingnews.com - March 31 at 4:56 PM
Medifast (MED) Lowered to "Hold" at Zacks Investment ResearchMedifast (MED) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 10:02 PM
Zacks Investment Research Lowers Medifast (MED) to HoldZacks Investment Research Lowers Medifast (MED) to Hold
www.americanbankingnews.com - March 29 at 11:27 AM
Under Armour, Medifast among Greater Baltimore stocks up through first quarterUnder Armour, Medifast among Greater Baltimore stocks up through first quarter
www.bizjournals.com - March 26 at 4:16 PM
Financial Analysis: Greencore Group (GNCGY) & Medifast (MED)Financial Analysis: Greencore Group (GNCGY) & Medifast (MED)
www.americanbankingnews.com - March 26 at 7:34 AM
Conagra (CAG) Beats on Q3 Earnings, Raises FY18 EPS ViewConagra (CAG) Beats on Q3 Earnings, Raises FY18 EPS View
finance.yahoo.com - March 23 at 4:19 PM
Can The Uptrend Continue for Medifast (MED)?Can The Uptrend Continue for Medifast (MED)?
finance.yahoo.com - March 23 at 4:19 PM
Medifast Inc (MED) Director Charles P. Connolly Sells 8,000 SharesMedifast Inc (MED) Director Charles P. Connolly Sells 8,000 Shares
www.americanbankingnews.com - March 22 at 7:14 PM
Zacks.com featured highlights include: Medifast, LCI, Vectrus, Duluth and PatrickZacks.com featured highlights include: Medifast, LCI, Vectrus, Duluth and Patrick
finance.yahoo.com - March 21 at 4:20 PM
Medifast Inc (MED) Director Charles P. Connolly Sells 7,500 SharesMedifast Inc (MED) Director Charles P. Connolly Sells 7,500 Shares
www.americanbankingnews.com - March 19 at 7:28 PM
Medifast Inc (MED) Announces $0.48 Quarterly DividendMedifast Inc (MED) Announces $0.48 Quarterly Dividend
www.americanbankingnews.com - March 16 at 5:54 PM
Medifast, Inc. Announces Quarterly DividendMedifast, Inc. Announces Quarterly Dividend
finance.yahoo.com - March 15 at 4:51 PM
Medifast Inc (MED) Director Sells $1,689,000.00 in StockMedifast Inc (MED) Director Sells $1,689,000.00 in Stock
www.americanbankingnews.com - March 13 at 10:11 PM
5 Stocks With Recent Price Strength to Maximize Your Returns5 Stocks With Recent Price Strength to Maximize Your Returns
finance.yahoo.com - March 13 at 6:15 PM
Medifast (MED) Upgraded to "Strong-Buy" at Zacks Investment ResearchMedifast (MED) Upgraded to "Strong-Buy" at Zacks Investment Research
www.americanbankingnews.com - March 10 at 6:06 AM

SEC Filings

Medifast (NYSE:MED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medifast (NYSE:MED) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medifast (NYSE MED) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.